Goldman Sachs’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $40.3M | Buy |
|
|||||
|
2025
Q2 | $12.2M | Sell |
|
|||||
|
2025
Q1 | $9.42M | Sell |
|
|||||
|
2024
Q4 | $17.5M | Buy |
|
|||||
|
2024
Q3 | $10.6M | Sell |
|
|||||
|
2024
Q2 | $13.8M | Buy |
|
|||||
|
2024
Q1 | $18.1M | Sell |
|
|||||
|
2023
Q4 | $17.2M | Buy |
|
|||||
|
2023
Q3 | $2.85M | Sell |
|
|||||
|
2023
Q2 | $7.85M | Buy |
|
|||||
|
2023
Q1 | $8.8M | Sell |
|
|||||
|
2022
Q4 | $8.43M | Buy |
|
|||||
|
2022
Q3 | $7.33M | Buy |
|
|||||
|
2022
Q2 | $5.46M | Buy |
|
|||||
|
2022
Q1 | $10.3M | Sell |
|
|||||
|
2021
Q4 | $17M | Buy |
|
|||||
|
2021
Q3 | $10.6M | Buy |
|
|||||
|
2021
Q2 | $3.88M | Buy |
|
|||||
|
2021
Q1 | $563K | Sell |
|
|||||
|
2020
Q4 | $1.73M | Sell |
|
|||||
|
2020
Q3 | $4.77M | Buy |
|